Clinical trial

Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance…

NCT00490503 · M.D. Anderson Cancer Center, Other · Completed

Key facts

NCT number NCT00490503
Title Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Official title Non-Invasive MRI and MRS Techniques for Assessing Therapeutic Response to Pre-surgical Chemotherapy in Breast Cancer Patients
Lead sponsor M.D. Anderson Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Breast Cancer
Intervention type Procedure
Interventions Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS)
Enrollment 20
Start date Oct 25, 2006
Primary completion Oct 18, 2022
Completion Oct 18, 2022
First posted Jun 22, 2007
Last update posted Oct 31, 2022
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies